1065099-78-6 Usage
Uses
Used in Pharmaceutical Industry:
2-Amino-5-methyloxazole-4-carboxylic acid ethyl ester is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure and properties make it a valuable component in the development of new drugs, contributing to medicinal chemistry and drug discovery.
Used in Agrochemical Industry:
Although the provided materials do not explicitly mention its use in the agrochemical industry, given its role as a building block in compound synthesis, it can be inferred that 2-Amino-5-methyloxazole-4-carboxylic acid ethyl ester may also be used in the agrochemical field for the production of various agrochemical compounds, potentially contributing to the development of pesticides or other agricultural chemicals.
Given the lack of specific applications in the provided materials, the above uses are inferred based on the compound's role as a building block in synthesis and its importance in the pharmaceutical industry. Further research or additional materials would be required to detail specific applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1065099-78-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,5,0,9 and 9 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1065099-78:
(9*1)+(8*0)+(7*6)+(6*5)+(5*0)+(4*9)+(3*9)+(2*7)+(1*8)=166
166 % 10 = 6
So 1065099-78-6 is a valid CAS Registry Number.
1065099-78-6Relevant articles and documents
5,5-BICYCLIC OXAZOLE OREXIN RECEPTOR ANTAGONISTS
-
, (2016/07/05)
The present invention is directed to 5,5-bicyclic oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and ps
(2-Aryl-5-methylimidazol-4-ylcarbonyl)guanidines and (2-aryl-5-methyloxazol-4-ylcarbonyl)guanidines as NHE-1 inhibitors
Lee, Sunkyung,Yi, Kyu Yang,Youn, Sung Jun,Lee, Byung Ho,Yoo, Sung-eun
scheme or table, p. 1329 - 1331 (2009/10/02)
A series of (2-aryl-5-methylimidazol-4-ylcarbonyl)guanidines and (2-aryl-5-methyloxazol-4-ylcarbonyl)guanidines were synthesized and evaluated as NHE-1 inhibitors. The structure-activity relationships well matched those of furan derivatives, which were previously investigated. The (2,5-disubstituted)phenyl compounds showed better activities than the other analogues in both imidazole and oxazole compounds. Especially, 2-(2,5-dichlorophenyl)imidazole 52, and 2-(2-methoxy-5-chlorophenyl)imidazole 54 compounds exhibited potent cardioprotective efficacy both in vitro and in vivo as well as high NHE-1 inhibitory activities.
